Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clarus appoints CMO and CSO

This article was originally published in Scrip

Executive Summary

Privately held biotech Clarus Therapeutics has hired Dr Theodore Danoff and Dr Wael Salameh as vice-president of clinical development and chief medical officer, and vice-president of medical affairs and chief scientific officer, respectively. Dr Danoff recently served as vice-president of clinical development and medical affairs at Endo Pharmaceuticals. Dr Salameh was previously on the medical faculties of Temple University and UCLA. He has also served as senior medical director and team leader for early clinical stage biomarker development at Genentech.

Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts